Validation of Lysyl Oxidase As a Prognostic Marker for Metastasis and Survival in Head and Neck Squamous Cell Carcinoma: Radiation Therapy Oncology Group Trial 90-03

PURPOSE: To validate lysyl oxidase (LOX), a hypoxia-related protein, as a marker for metastasis in an independent head and neck cancer (HNC) patient group enrolled onto a prospective trial. PATIENTS AND METHODS: We performed traditional immunohistochemical (IHC) staining and automated quantitative a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Le, Quynh-Thu, Harris, Jonathan, Magliocco, Anthony M., Kong, Christina S., Diaz, Roman, Shin, Brian, Cao, Hongbin, Trotti, Andy, Erler, Janine T., Chung, Christine H., Dicker, Adam, Pajak, Thomas F., Giaccia, Amato J., Ang, K. Kian
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2009
Assuntos:
Original Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2744270/
https://ncbi.nlm.nih.gov/pubmed/19667273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.20.6003
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares